Risk of second breast cancer in female Hodgkin's lymphoma survivors: a meta-analysis (Q34284202)

1 August 2017

0 references

Risk of second breast cancer in female Hodgkin's lymphoma survivors: a meta-analysis (English)

1 reference

1 August 2017

1 reference

Khaled M Abouelkhair

2

1 reference

ORCID Public Data File 2021

author name string

Ezzeldin M Ibrahim

1

1 reference

1 August 2017

Ghieth A Kazkaz

3

1 reference

1 August 2017

Osama A Elmasri

4

1 reference

1 August 2017

Meteb Al-Foheidi

5

1 reference

1 August 2017

language of work or name

English

0 references

publication date

28 May 2012

1 reference

1 August 2017

1 reference

1 August 2017

volume

12

1 reference

1 August 2017

page(s)

197

1 reference

Late effects in the era of modern therapy for Hodgkin lymphoma

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Hodgkin's lymphoma therapy: past, present, and future

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Updated recommendations for breast cancer screening

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Risk of breast cancer according to clinicopathologic features among long-term survivors of Hodgkin's lymphoma treated with radiotherapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

State-of-the-art Issues in Hodgkin’s Lymphoma Survivorship

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Systematic review: surveillance for breast cancer in women treated with chest radiation for childhood, adolescent, or young adult cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Second malignant neoplasms in survivors of pediatric Hodgkin's lymphoma treated with low-dose radiation and chemotherapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

The UK national breast cancer screening programme for survivors of Hodgkin lymphoma detects breast cancer at an early stage

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation dose

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Treatment of Hodgkin lymphoma: the past, present, and future.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Breast cancer after treatment of Hodgkin's lymphoma: risk factors that really matter.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Mammographic screening in women at increased risk of breast cancer after treatment of Hodgkin's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Pediatric hodgkin lymphoma: maximizing efficacy and minimizing toxicity

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

New malignancies following childhood cancer in the United States, 1973-2002.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

A comparison of mantle versus involved-field radiotherapy for Hodgkin's lymphoma: reduction in normal tissue dose and second cancer risk

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Radiation effects on development of HER2-positive breast carcinomas

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Risk of breast cancer in female survivors of childhood Hodgkin's disease in Britain: a population-based study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Meta-analysis of mortality and cancer incidence among workers in the synthetic rubber-producing industry

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Breast cancer risk following radiotherapy for Hodgkin lymphoma: modification by other risk factors

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Measuring inconsistency in meta-analyses

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Quantifying heterogeneity in a meta-analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Radiation effects on breast cancer risk: a pooled analysis of eight cohorts

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Radiation and breast carcinogenesis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Breast cancer after mantle irradiation for Hodgkin's disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Second malignant neoplasms after cancer in childhood and adolescence: a population-based case-control study in the 5 Nordic countries. The Nordic Society for Pediatric Hematology and Oncology. The Association of the Nordic Cancer Registries

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Second malignant neoplasms after treatment for Hodgkin's disease in childhood or adolescence

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Second malignancies after Hodgkin's disease: the Munich experience

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Breast cancer in women following supradiaphragmatic irradiation for Hodgkin's disease.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Carcinogenic effects of radiotherapy for breast cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Increased mortality after successful treatment for Hodgkin's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Bias in meta-analysis detected by a simple, graphical test

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Increased risk of breast cancer in splenectomized patients undergoing radiation therapy for Hodgkin's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Risk of subsequent malignant neoplasms among 1,641 Hodgkin's disease patients diagnosed in childhood and adolescence: a population-based cohort study in the five Nordic countries. Association of the Nordic Cancer Registries and the Nordic Society of

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Second malignancies after treatment for laparotomy staged IA-IIIB Hodgkin's disease: long-term analysis of risk factors and outcome.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Second cancer risk following Hodgkin's disease: a 20-year follow-up study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Carcinogenicity of antineoplastic agents in man

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Second cancers following antineoplastic therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Meta-analysis in clinical trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Second primary malignancy after Hodgkin's disease, ovarian cancer and cancer of the testis: a population-based cohort study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Leukemia following Hodgkin's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Letter: second malignancies complicating Hodgkin's disease in remission

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE)

6 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-197

Breast cancer after treatment of Hodgkin's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-197

Second cancers following pediatric Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-197

The risk of second malignant tumors and its consequences for the overall survival of Hodgkin's disease patients and for the choice of their treatment at presentation: analysis of a series of 1524 cases consecutively treated at the Florence Universit

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-197

High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the Late Effects Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-197

Malignant breast tumors after radiotherapy for a first cancer during childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-197

Risk of second malignant neoplasms among lymphoma patients with a family history of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-197

Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-197

Second cancer risk after chemotherapy for Hodgkin's lymphoma: a collaborative British cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-197

Clinical and pathologic features of breast cancers in women treated for Hodgkin's disease: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-197

Roles of radiation dose, chemotherapy, and hormonal factors in breast cancer following Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-197

Breast cancer screening in women previously treated for Hodgkin's disease: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-197

Screening mammography for young women treated with supradiaphragmatic radiation for Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-197

Breast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-197

Long-Term Solid Cancer Risk Among 5-Year Survivors of Hodgkin's Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-12-197

Second cancers among long-term survivors of Hodgkin's disease diagnosed in childhood and adolescence

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3416585

Management of breast cancer after Hodgkin's disease

28 October 2018

1 reference

12 December 2020

Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study

1 reference

12 December 2020

Solid tumors in patients treated for Hodgkin's disease: a report from the German Hodgkin Lymphoma Study Group

1 reference

12 December 2020

Breast cancer after childhood cancer: a report from the Childhood Cancer Survivor Study

1 reference

12 December 2020

High risk of breast carcinoma after irradiation of young women with Hodgkin's disease

1 reference

12 December 2020

Second malignancy after Hodgkin disease treated with radiation therapy with or without chemotherapy: long-term risks and risk factors

1 reference

12 December 2020

Long-term risk of second malignancy after treatment of Hodgkin's disease: the influence of treatment, age and follow-up time

1 reference

12 December 2020

Risk of breast cancer and breast cancer characteristics in women treated with supradiaphragmatic radiation for Hodgkin lymphoma: Mayo Clinic experience

1 reference

12 December 2020

Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study

1 reference

12 December 2020

Breast cancer following treatment of Hodgkin's disease--more reasons for less radiotherapy?

1 reference

12 December 2020

Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials

1 reference

12 December 2020

Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1980

1 reference

12 December 2020

Risk of second cancers after treatment for Hodgkin's disease

1 reference

12 December 2020

Mortality from breast cancer after irradiation during fluoroscopic examinations in patients being treated for tuberculosis

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-12-197

1 reference

Dimensions Publication ID

1 August 2017

0 references

1 reference

1 August 2017

1 reference